Nanobiotech Novan raises $5.1M; acne treatment in trials, competition looms
Nanotechnology company executives tell me one of their biggest challenges is finding the right application.
At the nanoscale, particles take on properties different than they do at the macroscale, which opens the door to a wealth of opportunities. In medicine, many companies pursue nanotechnology to improve delivery of a therapeutic compound. it looks like that’s what University of North Carolina at Chapel Hill spinout Novan Therapeutics is doing with its technology, though that wasn’t its initial focus. The company, now based in Research Triangle Park, has just closed on a $5.1 million fundraising round. The round follows a $6 million …
Read User's Comments0